CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1 Study to Evaluate Safety, Immunogenicity of the ChulaCov19 BNA159 mRNA Vaccine in Healthy Adults

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05231369
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:19.448146+00:00
Published At: 2023-02-10T00:00:00+00:00
Record Updated At: 2023-02-10
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Safety of 25 ug of ChulaCov19-BNA159 mRNA Vaccine", "Tolerability of 25 ug of ChulaCov19-BNA159 mRNA Vaccine", "Immune Response of 25 ug of ChulaCov19-BNA159 mRNA Vaccine", "Safety of 50 ug of ChulaCov19-BNA159 mRNA Vaccine", "Tolerability of 50 ug of ChulaCov19-BNA159 mRNA Vaccine", "Immune Response of 50 ug of ChulaCov19-BNA159 mRNA Vaccine", "Assess Which Dose is Appropriate to Use"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-02-10"
protocolSection.identificationModule.nctId: "NCT05231369"
protocolSection.identificationModule.officialTitle: "A Phase 1 Study to Evaluate Safety, Immunogenicity of the ChulaCov19 BNA159 mRNA Vaccine in Healthy Adults"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.